IGC Pharma, Inc. - COM NEW (IGC)

CUSIP: 45408X308

Q2 2022 13F Holders as of 30 Jun 2022

Type / Class
Equity / COM NEW
Total 13F shares
3,267,303
Share change
-910,633
Total reported value
$1,729,000
Put/Call ratio
33%
Price per share
$0.53
Number of holders
22
Value change
-$1,067,336
Number of buys
16
Number of sells
4

Security key

45408X308

Report period

Q2 2022

Institutions

22

Top holders

10

Top shareholders of IGC - IGC Pharma, Inc. - COM NEW (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
Mirae Asset Global Investments Co., Ltd.
13F
Company
class O/S missing
1,377,257
$1,307,000 31 Mar 2022
13F
BlackRock Finance, Inc.
13F
Company
class O/S missing
858,786
$815,000 31 Mar 2022
13F
VANGUARD GROUP INC
13F
Company
class O/S missing
645,799
$612,000 31 Mar 2022
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
class O/S missing
292,489
$277,000 31 Mar 2022
13F
STATE STREET CORP
13F
Company
class O/S missing
178,707
$170,000 31 Mar 2022
13F
BRIDGEWAY CAPITAL MANAGEMENT, LLC
13F
Company
class O/S missing
139,000
$132,000 31 Mar 2022
13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP
13F
Company
class O/S missing
119,977
$114,000 31 Mar 2022
13F
Vident Investment Advisory, LLC
13F
Company
class O/S missing
104,011
$99,000 31 Mar 2022
13F
IQ EQ FUND MANAGEMENT (IRELAND) Ltd
13F
Company
class O/S missing
97,235
$92,000 31 Mar 2022
13F
DEARBORN PARTNERS LLC
13F
Company
class O/S missing
96,901
$92,000 31 Mar 2022
13F
Rohit Goel
3/4/5
Senior Director of Finance&PAO
class O/S missing
235,000
$79,900 13 May 2021
GOLDMAN SACHS GROUP INC
13F
Company
class O/S missing
65,483
$62,000 31 Mar 2022
13F
NORTHERN TRUST CORP
13F
Company
class O/S missing
63,328
$60,000 31 Mar 2022
13F
John E. Lynch
3/4/5
Director
mixed-class rows
396,901
mixed-class rows
$45,696 31 May 2022
TRUIST FINANCIAL CORP
13F
Company
class O/S missing
36,667
$35,000 31 Mar 2022
13F
GROUP ONE TRADING LLC
13F
Company
class O/S missing
26,798
$25,000 31 Mar 2022
13F
Virtu Financial LLC
13F
Company
class O/S missing
22,708
$22,000 31 Mar 2022
13F
TWO SIGMA SECURITIES, LLC
13F
Company
class O/S missing
14,436
$14,000 31 Mar 2022
13F
UBS Group AG
13F
Company
class O/S missing
12,656
$12,000 31 Mar 2022
13F
JANE STREET GROUP, LLC
13F
Company
class O/S missing
11,991
$11,000 31 Mar 2022
13F
CITADEL ADVISORS LLC
13F
Company
class O/S missing
10,007
$10,000 31 Mar 2022
13F
Geneos Wealth Management Inc.
13F
Company
class O/S missing
3,200
$3,000 31 Mar 2022
13F
MORGAN STANLEY
13F
Company
class O/S missing
1,410
$1,000 31 Mar 2022
13F
Tower Research Capital LLC (TRC)
13F
Company
class O/S missing
1,364
$1,000 31 Mar 2022
13F
TORONTO DOMINION BANK
13F
Company
class O/S missing
1,106
$1,000 31 Mar 2022
13F
Fairfield Financial Advisors, LTD
13F
Company
class O/S missing
500
$474 31 Mar 2022
13F

Institutional Holders of IGC Pharma, Inc. - COM NEW (IGC) as of Q2 2022

As of 30 Jun 2022, IGC Pharma, Inc. - COM NEW (IGC) was held by 22 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 3,267,303 shares. The largest 10 holders included BlackRock Inc., VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, RENAISSANCE TECHNOLOGIES LLC, STATE STREET CORP, SUSQUEHANNA INTERNATIONAL GROUP, LLP, BRIDGEWAY CAPITAL MANAGEMENT, LLC, CITADEL ADVISORS LLC, DEARBORN PARTNERS LLC, and Vident Investment Advisory, LLC. This page lists 22 institutional shareholders reporting positions in this security for the Q2 2022 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q2 2022 vs Q1 2022 Across Filers

Q1 2022 holders
22
Q2 2022 holders
22
Holder diff
0
Investor Q1 2022 Shares Q2 2022 Shares Share Diff Share Chg % Q1 2022 Value $ Q2 2022 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .